中国现代医生杂志欢迎您.   今天是:          
肖醒香1 张潭军2.缬沙坦联合氨氯地平治疗慢性肾脏病合并肾性高血压的效果[J].中国现代医生,2021,59(3):45-48
缬沙坦联合氨氯地平治疗慢性肾脏病合并肾性高血压的效果
Effect of valsartan combined with amlodipine in the treatment of chronic kidney disease complicated with renal hypertension
  
DOI:
中文关键词:  慢性肾脏病  肾性高血压  缬沙坦  氨氯地平
英文关键词:Chronic kidney disease  Renal hypertension  Valsartan  Amlodipine
基金项目:
作者单位
肖醒香1 张潭军2 1.广东省惠州市第六人民医院肾内科广东惠州 5162112.广东省惠州市第六人民医院呼吸内科广东惠州 516211 
摘要点击次数: 482
全文下载次数: 1326
中文摘要:
      目的 探讨缬沙坦联合氨氯地平治疗慢性肾脏病合并肾性高血压的疗效及安全性。方法 选取2017 年5 月至2018 年12 月于我院进行治疗的慢性肾脏病合并肾性高血压患者,采用随机数字表法分为对照组(n=55)和观察组(n=55)。对照组行氨氯地平治疗方案,观察组行缬沙坦联合氨氯地平治疗方案。比较两组患者治疗效果、血压变化、肾功能变化及药物安全性。结果 观察组治疗总有效率为90.91%,高于对照组的72.73%(P<0.05)。两组治疗前SBP 和DBP 比较,差异无统计学意义(P>0.05);两组治疗后SBP 和DBP 均下降(P<0.05),且观察组SBP和DBP 下降程度更为显著(P<0.05)。两组治疗前肾功能指标比较,差异无统计学意义(P>0.05);两组治疗后GFR、24 h 尿蛋白定量、Scr、BUN 水平均改善(P<0.05),且观察组改善程度更显著(P<0.05)。两组患者治疗期间无严重不良反应发生,药物治疗安全性高。结论 慢性肾脏病合并肾性高血压患者行缬沙坦联合氨氯地平治疗,能有效改善患者血压及肾功能,药物安全性高,具有进一步探讨的临床意义。
英文摘要:
      Objective To investigate the efficacy and safety of valsartan combined with amlodipine in the treatment of patients with chronic kidney disease complicated with renal hypertension.Methods Patients with chronic kidney disease complicated with renal hypertension who were treated in our hospital from May 2017 to December 2018 were selected and divided into the observation group(n=55) and the control group(n=55) according to the random number table method.The control group was treated with amlodipine,while the observation group was treated with valsartan combined with amlodipine.The therapeutic effect,changes in blood pressure,renal function and drug safety were compared between the two groups.Results The total effective rate of 90.91% in the observation group was higher than 72.73% in the control group(P<0.05).Before treatment,there was no significant difference in SBP and DBP between the two groups(P>0.05).After treatment,SBP and DBP decreased in both group(P<0.05),and the decrease degree of SBP and DBP in the observation group was more significant(P<0.05).Before treatment,there was no significant difference in renal function indexes between the two groups(P>0.05).After treatment,the level of GFR,24-hour urinary protein quantity,Scr,BUN and other indexes were improved in both groups (P<0.05),more significantly in the observation group(P<0.05).No serious adverse reactions occurred during the treatment in the two groups,and the drug was very safe for the treatment.Conclusion Valsartan combined with amlodipine for the treatment of patients with chronic kidney disease complicated with renal hypertension can effectively improve the blood pressure and renal function,and with good drug safety,which has clinical significance for further discussion.
查看全文  查看/发表评论  下载PDF阅读器
关闭
    • 关键词 :
    • 中国医生
    • 中国现代医生
    • 中国临床医生
    • 中国医师
    • 主任医师
    • 中国医学
    • 中华医学
    • 中国医院
    • 中国医药
    • 中国医疗
    • 现代医生
    • 现代医学
    • 现代医药
    • 现代医院
    • 现代药物
    • 现代护理
    • 现代临床
    • 医学杂志
    • 药学杂志
    • 医药杂志
    • 医生杂志
    • 医师杂志
    • 医疗杂志
    • 医药期刊
    • 医学期刊
    • 医药卫生期刊
    • 医药论文
    • 医学论文
    • 科研论文
    • 职称论文
    function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FF4EC6B96077DFE7B521037A680569BC8ADE393DF052BCFF1DBBEE09B7C7A38917C5DE74A907172EC5465658297617C193B71496F3DD7AF8E3092C9365C590F8A7556E2D9387BB9728038F529A6C3C7FA12D71F21297F5128EF730AEAD2C11E528ACF0124CFA1C33420E98AC620C92AF00D14A56BBD12A61CD0D830C32701C92&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=8EDAEC11C165015425CEEA15366CB0A7&yid=9475FABC7A03F4AB&aid=&vid=&iid=38B194292C032A66&sid=94E7F66E6C42FA23&eid=B6DA1AC076E37400&fileno=2021892&flag=1&is_more=0">